tiprankstipranks
Trending News
More News >
Chemomab Therapeutics (CMMB)
NASDAQ:CMMB

Compare Chemomab Therapeutics (CMMB) vs. Competitors

Compare
324 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Chemomab Therapeutics
$1.55
$9.54M
-0.90
-79.53%
2 Buy
0 Hold
0 Sell
Moderate Buy
Tenax Therapeutics
$12.95
$78.11M
-11.42
115.83%
4 Buy
0 Hold
0 Sell
Strong Buy
Q32 Bio
$3.88
$47.74M
-1.15
31.35%
1 Buy
1 Hold
0 Sell
Moderate Buy
Passage Bio
$11.50
$35.88M
-0.83
3.34%
4 Buy
0 Hold
0 Sell
Strong Buy
CalciMedica
$0.90
$12.97M
-0.42
-73.83%
1 Buy
1 Hold
0 Sell
Moderate Buy
Longeveron
$0.56
$11.94M
-0.40
-65.19%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CMMB
Chemomab Therapeutics
1.67
-6.61
-79.83%
TENX
Tenax Therapeutics
12.95
6.95
115.83%
QTTB
Q32 Bio
3.98
0.72
22.09%
PASG
Passage Bio
12.07
-0.13
-1.07%
CALC
CalciMedica
0.67
-1.89
-73.83%
LGVN
Longeveron
0.54
-0.96
-64.27%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts